AzTrials
AzTrials

ACL InjuryPREDICT-ACLv2NCT05897970

Association Between 4-Month Isokinetic Testing Measures and Second Knee Injuries After Primary Anterior Cruciate Ligament Reconstruction

An observational study of ACL Injury and Knee Injuries, run by University Hospital, Caen at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Anterior cruciate ligament (ACL) is a frequent and disabling injury in athletes. Most of the time, ACL reconstruction (ACLR) is consider for regaining function and returning to preinjury sports while reducing the risk of secondary injuries. Read more about this study

Who is it for?
Ages 16 to 55 years
Conditions the study is for
ACL Injury, Knee Injuries, Muscle Weakness
What is being tested?
Return-to-sport (RTS) follow-up
How many people
150 participants
Where
1 siteFrance
Study dates
1 May 2021to 1 May 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 55 years
  • All sexes
  • Child, Adult

Study population: All sports patients included in the sport medicine follow-up protocole with isokinetic muscular assessment at 3-4 months after ACL reconstruction surgery since January 2017 with a minium 2 years follow-up in the sports medicine department, Return To Sport Process

Who may be able to join

  • Patients who have had an ACL reconstruction surgery (isolated or associated with other meniscal or ligamentary surgery) Patient included in the sport medicine follow-up protocole with intermediate and final isokinetic muscular assessment at 3-4 months Patient who received the information form Patients with access to the Internet

Who cannot join

  • Patient who did not participate in all follow-up consultations and isokinetic muscular assessments Patients who had a previous knee surgery before the ACLR Cognitive or sensory impairment making it impossible to understand the information form Neurological, traumatic or osteoarticular history responsible for muscle imbalance prior to surgery

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Caen Normandie

    Caen, 14000

Other trials in France

About this study

Official title: Association Between 4-Month Isokinetic Testing Measures and Second Knee Injuries After

Anterior cruciate ligament (ACL) is a frequent and disabling injury in athletes. Most of the time, ACL reconstruction (ACLR) is consider for regaining function and returning to preinjury sports while reducing the risk of secondary injuries. However, the risk of secondary severe knee injury is increased after ACLR, especially in athletes returning to strenuous activities. If strength symmetry is considered as an important factor in the Return-to-sport (RTS) decision, there is conflicting data about the association between strength symmetry and the risk of second knee injury after ACLR. The main objective of this study was to test if knee muscles strength symmetry at 4 months was associated with the psychological readiness and incidence of subsequent severe injury of both knees at a minimum 2 years follow-up after ACL-R.

Being tested
Return-to-sport (RTS) follow-up
Medical subject headings
Anterior Cruciate Ligament Injuries, Knee Injuries, Muscle Weakness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Return-to-sport (RTS) follow-upDiagnostic test

    All sports patients who had a muscle evaluation at 3-4 months after ACLR since January 2017

Study groups in NCT05897970
Study groupRoleWhat they receive
ACLR patients with Return-to-sport (RTS) follow-upAll sports patients who had a muscle evaluation at 3-4 months after ACLR since January 2017
Receives: Diagnostic Test: Return-to-sport (RTS) follow-up

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Strength

    Measurement of knee extensors and flexors peak strength (in newton.meter, Nm) on isokinetic dynamometer.

    Measured: ACL group: Two evaluations on both injured and healthy knees: 3-4 months after surgery; Routine practice following guidelines]

Secondary outcomes (4)
  1. Individual characteristics

    Personal characteristics recorded in the medical report as age, gender, type of sport and sport level of practice and return to sport after the surgery and severe reinjury on the operated knee or contralateral knee.

    Measured: ACLR group: Two follow-up medical consultations: (1) 4 months after surgery and (2) 2 years after the surgery for return to sport and reinjury;

  2. Surgery characteristics

    Surgery characteristics recorded in the medical report as the type of surgery, the surgery duration

    Measured: ACLR group: Two follow-up medical consultations 4 months after surgery

  3. Re-injuries

    Web based questionnaire about any sever knee injury (meniscus or ACL) after the primary ACLR

    Measured: ACLR group: One evaluation with a minimum 2 years follow-up after the surgery

  4. Anterior Cruciate Ligament-Return to Sport after Injury (ACL-RSI) scale.

    Web based questionnaire with completion of the Anterior Cruciate Ligament-Return to Sport after Injury (ACL-RSI) scale.

    Measured: ACLR group: One evaluation with a minimum 2 years follow-up after the surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2023
  2. Study start1 May 2021
  3. Primary completion1 May 2021
  4. Study completion1 May 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05897970
Sponsor's protocol ID
PREDICT-ACLv2
Acronym
PREDICT-ACLv2
Status last verified
Jun 2023
First submitted
1 Jun 2023
Last updated
26 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of ACL Injury and Knee Injuries, run by University Hospital, Caen at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Strength (time frame: ACL group: Two evaluations on both injured and healthy knees: 3-4 months after surgery; Routine practice following guidelines]). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
PREDICT-ACLv2 Clinical Trial NCT05897970 | AzTrials